RAPT Therapeutics Inc (RAPT)

1.69 -0.12 (-6.63%) USD  |  NASDAQ  |  Dec 27, 16:00
1.70 +0.01 (+0.59%) After-Hours: 20:00
More

RAPT Therapeutics Research and Development Expense (Quarterly): 13.34M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for RAPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
AbbVie Inc 2.13B
Biomarin Pharmaceutical Inc 184.90M
Arbutus Biopharma Corp 14.27M
Assembly Biosciences Inc 13.52M
GlycoMimetics Inc 1.715M